COVID-19 and diabetes: What does the clinician need to know?

被引：37
作者：
Papadokostaki, Eleni [1 ]
Tentolouris, Nikolaos [2 ]
Liberopoulos, Evangelos [3 ]
机构：
[1] Gen Hosp Heraklion Venizeleio Pananeio, Dept Med, Iraklion 71409, Greece
[2] Natl & Kapodistrian Univ Athens, Laiko Gen Hosp, Dept Propaedeut Internal Med 1, Med Sch,Diabet Ctr, Athens, Greece
[3] Univ Ioannina, Fac Med, Dept Med, Ioannina 45110, Greece
来源：
PRIMARY CARE DIABETES | 2020年 / 14卷 / 05期
关键词：
SARS-CoV-2; COVID-19; Diabetes mellitus; MORTALITY; MELLITUS; OUTCOMES; RISK; COMORBIDITIES; SEVERITY;
D O I：
10.1016/j.pcd.2020.06.010
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
COVID-19 and diabetes are currently two global pandemics. Epidemiological studies indicate that diabetes is the second most common comorbidity in COVID-19. This review aims to summarize currently available data about prevalence, possible pathophysiological mechanisms and management of patients with diabetes and COVID-19. (C) 2020 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码：558 / 563
页数：6
相关论文
共 57 条
[31]   Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China [J].
Li, Bo ;
Yang, Jing ;
Zhao, Faming ;
Zhi, Lili ;
Wang, Xiqian ;
Liu, Lin ;
Bi, Zhaohui ;
Zhao, Yunhe .
CLINICAL RESEARCH IN CARDIOLOGY, 2020, 109 (05) :531-538
[32]   Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China [J].
Li, Juyi ;
Wang, Xiufang ;
Chen, Jian ;
Zhang, Hongmei ;
Deng, Aiping .
JAMA CARDIOLOGY, 2020, 5 (07) :825-830
[33]   Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics [J].
Maddaloni, Ernesto ;
Buzzetti, Raffaella .
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2020, 36 (07)
[34]   Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19 [J].
Mancia, Giuseppe ;
Rea, Federico ;
Ludergnani, Monica ;
Apolone, Giovanni ;
Corrao, Giovanni .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25) :2431-2440
[35]   Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy [J].
Onder, Graziano ;
Rezza, Giovanni ;
Brusaferro, Silvio .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18) :1775-1776
[36]   Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? [J].
Pal, Rimesh ;
Bhadada, Sanjay K. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 163
[37]   Severe obesity, increasing age and male sex are independently associated with worse in -hospital outcomes, and higher in -hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York [J].
Palaiodimos, Leonidas ;
Kokkinidis, Damianos G. ;
Li, Weijia ;
Karamanis, Dimitrios ;
Ognibene, Jennifer ;
Arora, Shitij ;
Southern, William N. ;
Mantzoros, Christos S. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2020, 108
[38]  
Pasquel F.J., 2020, J DIABETES SCI TECHN
[39]   SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons? [J].
Pitocco, Dario ;
Tartaglione, Linda ;
Viti, Luca ;
Di Leo, Mauro ;
Pontecorvi, Alfredo ;
Caputo, Salvatore .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2020, 163
[40]   Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC [J].
Raj, V. Stalin ;
Mou, Huihui ;
Smits, Saskia L. ;
Dekkers, Dick H. W. ;
Mueller, Marcel A. ;
Dijkman, Ronald ;
Muth, Doreen ;
Demmers, Jeroen A. A. ;
Zaki, Ali ;
Fouchier, Ron A. M. ;
Thiel, Volker ;
Drosten, Christian ;
Rottier, Peter J. M. ;
Osterhaus, Albert D. M. E. ;
Bosch, Berend Jan ;
Haagmans, Bart L. .
NATURE, 2013, 495 (7440) :251-254
123456